Free Trial

agilon health, inc. (NYSE:AGL) Shares Sold by Bank of America Corp DE

agilon health logo with Medical background

Bank of America Corp DE trimmed its holdings in agilon health, inc. (NYSE:AGL - Free Report) by 34.3% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,301,316 shares of the company's stock after selling 1,727,248 shares during the quarter. Bank of America Corp DE owned about 0.80% of agilon health worth $6,273,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AGL. Capital International Investors raised its stake in shares of agilon health by 72.0% during the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after purchasing an additional 9,346,295 shares in the last quarter. Algert Global LLC raised its position in agilon health by 1,042.7% in the fourth quarter. Algert Global LLC now owns 2,108,687 shares of the company's stock valued at $4,007,000 after purchasing an additional 1,924,157 shares during the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of agilon health by 49.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock worth $8,629,000 after acquiring an additional 1,498,524 shares during the last quarter. Susquehanna Fundamental Investments LLC acquired a new stake in agilon health during the fourth quarter worth approximately $1,616,000. Finally, Alberta Investment Management Corp acquired a new stake in agilon health in the fourth quarter valued at approximately $1,564,000.

agilon health Trading Up 0.2%

Shares of NYSE AGL traded up $0.01 during midday trading on Friday, reaching $2.24. 1,871,096 shares of the stock were exchanged, compared to its average volume of 4,949,483. The company has a 50 day simple moving average of $3.83 and a 200 day simple moving average of $3.17. The stock has a market capitalization of $925.18 million, a P/E ratio of -2.38 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health, inc. has a twelve month low of $1.50 and a twelve month high of $7.73.

agilon health (NYSE:AGL - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.03 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.50 billion. During the same quarter last year, the firm earned ($0.02) EPS. The firm's revenue for the quarter was down 4.5% on a year-over-year basis. As a group, equities analysts expect that agilon health, inc. will post -0.59 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have issued reports on AGL. Cowen restated a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Sanford C. Bernstein raised agilon health from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $3.30 to $8.50 in a research report on Tuesday, April 8th. Citigroup upgraded agilon health from a "neutral" rating to a "buy" rating and upped their price target for the stock from $3.25 to $5.00 in a research note on Friday, April 25th. Robert W. Baird lowered their price target on agilon health from $6.00 to $5.00 and set a "neutral" rating on the stock in a report on Tuesday, April 15th. Finally, Stifel Nicolaus raised their price target on agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a report on Wednesday, February 26th. Two equities research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, agilon health has a consensus rating of "Hold" and a consensus target price of $4.79.

Read Our Latest Research Report on AGL

About agilon health

(Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Articles

Institutional Ownership by Quarter for agilon health (NYSE:AGL)

Should You Invest $1,000 in agilon health Right Now?

Before you consider agilon health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.

While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This Unique Robotaxi Play Could Deliver 10X Returns
NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines